A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Our innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia. Click here to view our facilities.
We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
We will be exceptional, always.
Almac Awards ArchiveLearn more
A unique culture delivering exceptional solutionsLearn more
Almac History, Culture and Values
Watch our History, Culture and Values Video to learn more about our background and vision for a successful future.Learn more
Company Overview Video
Learn more about our extensive pharmaceutical development and manufacturing services and global capabilities.Learn more
Almac is a global provider of pharmaceutical support services with thousands of employees situated throughout its global facilities. It is Almac’s policy to conduct all business in an honest and ethical manner.Learn more
Meet Almac Group’s Executive team responsible for the strategic direction of the organisation and committed to “advancing human health” globally.Learn more
Core Values & Vision
Our ultimate goal is to help advance human health globally. We are at the forefront of improving efficiency in the development of new medicines.Learn more
For over 50 years, Almac has supported the global Biopharmaceutical industry with their drug development activities and bringing new drugs to market to advance human health.Learn more
As testament to our expertise and strong global performance, Almac is proud to have been recognised by various bodies and received an array of awards.Learn more
Sir Allen McClay
Northern Ireland lost its most passionate, visionary and generous man. Sir Allen McClay (Allen, as he preferred to be called) passed away on Tuesday 12th January, 2010.Learn more
Tax Strategy: Almac Approach
The Almac Group is a group of companies operating in the highly regulated and risk-averse pharmaceutical and biotech sectors. We adopt this same low risk strategy in our approach to our tax affairs and tax strategy.Learn more
Our approach to plastic
Almac Group is committed to carrying out its business of ethical pharmaceutical products manufacture and services provision in a manner which will not harm its employees, customers, contractors, visitors, neighbours or the environment.Learn more